ADVERTISEMENT

Trastuzumab deruxtecan in patients with breast cancer and brain metastases

Heather Mason   |   Medical News   |   12 August 2022
ADVERTISEMENT

According to an article published in Nature Medicine , trastuzumab deruxtecan showed high intracranial response rates in patients with active brain metastases associated with human epidermal growth factor receptor 2 (HER2)-positive breast cancer, warranting its further clinical exploration.

The clinical trial enrolled 15 patients with HER2-positive breast cancer and newly diagnosed...

          

January Challenge

Ends in 2d 16h
left
right

Topic Challenges

left
right